ALLE vs AMLX · P/E 21, rev $2.19B vs $561.6M cap
Allegion PLC (ALLE) versus Amylyx Pharmaceuticals Inc (AMLX) — a side-by-side from cached financials, not a winner call.
Allegion PLC (ALLE) is a security & protection services company listed on US.
Amylyx Pharmaceuticals Inc (AMLX) is a biotechnology company listed on US.
Latest reported ALLE revenue for 2026-06-30 was $2.19B. Net income was $322.7M. ALLE currently screens at market cap $12.71B and trailing P/E 20.7.
Latest reported AMLX revenue for 2025-12-31 was $0. Net income was -$144.7M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. AMLX currently screens at market cap $561.6M.
ALLE currently screens at market cap $12.71B and trailing P/E 20.7. AMLX currently screens at market cap $561.6M.
Not investment advice. Open the ALLE and AMLX stock pages for the full models.
Not investment advice.